Publications

29. Chipps, B.E., Chipps, D.R. Approach to Difficult Pediatric Asthmatic. Opin Pulm Med. 5:52-57, 1999.

28. The IMpact Study Group. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. Pediatrics 102:531-537, 1998. View

27. Loughlin, G.M., Brouillette R.T., Brooke L.J., Carroll J.L., Chipps, B.E., et al. Standards and Indications for Cardiopulmonary Sleep Studies In Children. American Journal of Respiratory and Critical Care Medicine. Vol 153, No. 2:866-878, 1996.

26. Smith, D.W., Frankel, L.R., Derish, M.T., Moody, R.R., Black, L.E., Chipps, B.E., Mathers, L.H.: High frequency jet ventilation in children with the adult respiratory distress syndrome complicated by pulmonary barotrauma. Pediatr Pulmonol. 15:279-286, 1993.

25. Chipps, B.E., Sullivan, W.F., Portnoy, J.M.,: Alpha 2A interferon for treatment of bronchiolitis caused by RSV. Pediatr Infect Dis J. 12:653-658, 1993.

24. Chipps, B.E., Naumann, P.F., Wong, G.A., Raabe, O.G.: Clinical Comparison of Gentle-Haler Actuator and Aerochamber Spacer for Metered Dose Inhaler (MDI) Use by Asthmatics. Respir Care 37:1414-1422, 1992.

23. Chipps, B.E., Blackney, D.A., Moody, R.R., Marino, J.T., Black, L.E., Ridell, R.C., Wong, G.A.: Vortan high output extended aerosol respiratory therapy for delivery on continuously nebulized terbutaline for the treatment of acute bronchospasm. Pediatric
Asthma, Allergy and Immunology 4:271-277, 1990.

22. Chipps, B.E., McClurg, D., Freidman, E.M., Adams, G.L.: Respiratory papillomas: Presentation before six months. Pediatric Pulmonology 9:125-130, 1990.

21. Davidson Ward, S.L., Keens, T.G., Chan, L.S., Ph.D., Chipps, B.E., et al: Sudden Infant Death Syndrome in infants evaluated by apnea programs in California. Pediatrics 77:451-458, 1986.

***Updated 1/23/2022***

FROM CAPITAL ALLERGY & RESPIRATORY DISEASE CENTER

COVID VACCINE ALERT

Please be aware that we recommend patients do not receive allergy shots of biologics injections for 7 days after receiving a COVID vaccine. This may cause a need to reschedule an injection appointment. Please call our office to change appointment times or for any questions or concerns. You can also contact us through the patient portal.

************************************************

COVID Vaccine Update

Click Here to learn more

We do not expect to be a site for administration of the COVID19 vaccine.  Please check with your local public health department.

Use this link for more information on the state of California’s tiered system for vaccine administration.

https://covid19.ca.gov/vaccines/#When-can-I-get-vaccinated

************************************************

Due to current recommendations made by the US Government/CDC – The Following will go into effect until further notice.

View More

New Injection Hours – Effective 1/10/2022

Folsom Office
Monday 8:00-11:30 / 1-4:30
Tuesday Closed
Wednesday 8:00-11:30 / 1-4:30
Thursday 8:00-11:30 / 1-4:30
Friday 8:00-11:30 / 1-4:30

Roseville Office
Monday 9:00-11:30 / 1-5:30
Tuesday 8:00-11:30 / 1-4:30
Wednesday 8:00-11:30 / 1-4:30
Thursday 8:00-11:30 / 1-4:30
Friday 8:00-11:30 / 1-4:30

Sacramento
Monday 9:00-4:30
Tuesday 8:00-5:30
Wednesday 8:00-11:30 / 1-4:30
Thursday 9:00-4:30
Friday 8:00-4:30